Diabetes Mellitus, Type 1 Clinical Trials in Miami, Florida

3 studies are recruiting for diabetes mellitus, type 1 in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

    The main purpose of this study is to learn more how tirzepatide affects stomach emptying in participants with Type 1 Diabetes Mellitus (T1DM) and overweight or obesity. Participation in this study will last about 8 weeks, including screening and follow-up.

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Clinical Pharmacology of Miami, Miami, Florida
    Run by
    Eli Lilly and Company

    See if you can join NCT07803744 on ClinicalTrials.gov

  2. A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

    This study will evaluate the safety, tolerability and efficacy of VX-880 infusion and VX-017 infusion in participants with type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    UHealth Diabetes Research Institute, Miami, Florida
    Locations
    29 in total
    Run by
    Vertex Pharmaceuticals Incorporated

    See if you can join NCT04786262 on ClinicalTrials.gov

  3. Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

    The brief purpose of this research study is to learn about the safety and efficacy of intra-arterial administration of CELZ-201 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D).

    Stage
    Phase 1
    Ages
    18 to 35
    Site
    Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida
    Run by
    Creative Medical Technology Holdings Inc

    See if you can join NCT05626712 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.